Virax has one of the most advanced clinical programs on ASX, with 5 mid-stage clinical trials running under two separate INDs over next 12 months
Just compare us with IMU , they will have 1.3 to 1.4B shares post spp with maybe 4-5m cash post current spp , they have a value of 16-18m post spp at current price of 1.2c and will start their only phase 1b trial in mid 2015 .
VHL , market value just above 8m and cash just above $3m
Based on IMU alone we should be valued above 2c imo , i think we may have seen the last of the sellers , those who bought between 0.5 and 0.6 between may and october.
- Forums
- ASX - By Stock
- VHL
- HotCopper Coverage
HotCopper Coverage, page-9
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)